| UniProt ID | CRTC1_HUMAN | |
|---|---|---|
| UniProt AC | Q6UUV9 | |
| Protein Name | CREB-regulated transcription coactivator 1 | |
| Gene Name | CRTC1 {ECO:0000312|HGNC:HGNC:16062} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 634 | |
| Subcellular Localization | Cytoplasm . Nucleus . Cytoplasmic when phosphorylated by SIK or AMPK and when sequestered by 14-3-3 proteins (PubMed:16817901). Translocated to the nucleus on Ser-151 dephosphorylation, instigated by a number of factors including calcium ion and cAMP | |
| Protein Description | Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates the expression of specific CREB-activated genes such as the steroidogenic gene, StAR. Potent coactivator of PGC1alpha and inducer of mitochondrial biogenesis in muscle cells. In the hippocampus, involved in late-phase long-term potentiation (L-LTP) maintenance at the Schaffer collateral-CA1 synapses. May be required for dendritic growth of developing cortical neurons (By similarity). In concert with SIK1, regulates the light-induced entrainment of the circadian clock. In response to light stimulus, coactivates the CREB-mediated transcription of PER1 which plays an important role in the photic entrainment of the circadian clock.; (Microbial infection) Plays a role of coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR).. | |
| Protein Sequence | MATSNNPRKFSEKIALHNQKQAEETAAFEEVMKDLSLTRAARLQLQKSQYLQLGPSRGQYYGGSLPNVNQIGSGTMDLPFQTPFQSSGLDTSRTTRHHGLVDRVYRERGRLGSPHRRPLSVDKHGRQADSCPYGTMYLSPPADTSWRRTNSDSALHQSTMTPTQPESFSSGSQDVHQKRVLLLTVPGMEETTSEADKNLSKQAWDTKKTGSRPKSCEVPGINIFPSADQENTTALIPATHNTGGSLPDLTNIHFPSPLPTPLDPEEPTFPALSSSSSTGNLAANLTHLGIGGAGQGMSTPGSSPQHRPAGVSPLSLSTEARRQQASPTLSPLSPITQAVAMDALSLEQQLPYAFFTQAGSQQPPPQPQPPPPPPPASQQPPPPPPPQAPVRLPPGGPLLPSASLTRGPQPPPLAVTVPSSLPQSPPENPGQPSMGIDIASAPALQQYRTSAGSPANQSPTSPVSNQGFSPGSSPQHTSTLGSVFGDAYYEQQMAARQANALSHQLEQFNMMENAISSSSLYSPGSTLNYSQAAMMGLTGSHGSLPDSQQLGYASHSGIPNIILTVTGESPPSLSKELTSSLAGVGDVSFDSDSQFPLDELKIDPLTLDGLHMLNDPDMVLADPATEDTFRMDRL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Phosphorylation | SNNPRKFSEKIALHN CCCHHHHHHHHHHHC | 40.80 | 24719451 | |
| 11 (in isoform 2) | Phosphorylation | - | 40.80 | 24719451 | |
| 13 | Ubiquitination | NPRKFSEKIALHNQK CHHHHHHHHHHHCHH | 31.89 | 29967540 | |
| 36 | Phosphorylation | EEVMKDLSLTRAARL HHHHHHHHHHHHHHH | 37.52 | 24719451 | |
| 47 | Ubiquitination | AARLQLQKSQYLQLG HHHHHHHHHHCEEEC | 48.39 | 22817900 | |
| 47 (in isoform 3) | Ubiquitination | - | 48.39 | 21890473 | |
| 47 (in isoform 1) | Ubiquitination | - | 48.39 | 21890473 | |
| 47 (in isoform 2) | Ubiquitination | - | 48.39 | 21890473 | |
| 48 (in isoform 2) | Phosphorylation | - | 15.88 | 27642862 | |
| 48 | Phosphorylation | ARLQLQKSQYLQLGP HHHHHHHHHCEEECC | 15.88 | 28796482 | |
| 50 | Phosphorylation | LQLQKSQYLQLGPSR HHHHHHHCEEECCCC | 11.96 | 28796482 | |
| 50 (in isoform 2) | Phosphorylation | - | 11.96 | 27642862 | |
| 60 | Phosphorylation | LGPSRGQYYGGSLPN ECCCCCCCCCCCCCC | 13.60 | 28450419 | |
| 61 | Phosphorylation | GPSRGQYYGGSLPNV CCCCCCCCCCCCCCC | 13.71 | 28450419 | |
| 64 (in isoform 2) | Phosphorylation | - | 35.97 | 28348404 | |
| 64 | Phosphorylation | RGQYYGGSLPNVNQI CCCCCCCCCCCCCEE | 35.97 | 28674151 | |
| 73 | Phosphorylation | PNVNQIGSGTMDLPF CCCCEECCCCCCCCC | 32.49 | 28464451 | |
| 75 | Phosphorylation | VNQIGSGTMDLPFQT CCEECCCCCCCCCCC | 14.81 | 28464451 | |
| 82 | Phosphorylation | TMDLPFQTPFQSSGL CCCCCCCCCCCCCCC | 26.84 | 27080861 | |
| 103 | Methylation | RHHGLVDRVYRERGR HHHCHHHHHHHHCCC | 21.64 | 115918753 | |
| 113 | Phosphorylation | RERGRLGSPHRRPLS HHCCCCCCCCCCCCC | 23.33 | 23401153 | |
| 120 | Phosphorylation | SPHRRPLSVDKHGRQ CCCCCCCCCCCCCCC | 30.84 | 23403867 | |
| 123 | Acetylation | RRPLSVDKHGRQADS CCCCCCCCCCCCCCC | 45.89 | 11792777 | |
| 129 (in isoform 2) | Phosphorylation | - | 42.29 | 24719451 | |
| 130 | Phosphorylation | KHGRQADSCPYGTMY CCCCCCCCCCCCCEE | 21.73 | 28857561 | |
| 136 (in isoform 2) | Phosphorylation | - | 2.48 | 24719451 | |
| 137 | Phosphorylation | SCPYGTMYLSPPADT CCCCCCEEECCCCCC | 12.13 | 28348404 | |
| 139 | Phosphorylation | PYGTMYLSPPADTSW CCCCEEECCCCCCCC | 16.02 | 25159151 | |
| 144 | Phosphorylation | YLSPPADTSWRRTNS EECCCCCCCCCCCCC | 32.09 | 26074081 | |
| 145 | Phosphorylation | LSPPADTSWRRTNSD ECCCCCCCCCCCCCC | 21.09 | 26074081 | |
| 146 (in isoform 2) | Phosphorylation | - | 8.89 | 24719451 | |
| 149 | Phosphorylation | ADTSWRRTNSDSALH CCCCCCCCCCCCCCC | 30.42 | 23927012 | |
| 151 | Phosphorylation | TSWRRTNSDSALHQS CCCCCCCCCCCCCCC | 32.12 | 23927012 | |
| 153 | Phosphorylation | WRRTNSDSALHQSTM CCCCCCCCCCCCCCC | 32.33 | 23401153 | |
| 155 (in isoform 2) | Phosphorylation | - | 4.35 | 24719451 | |
| 158 | Phosphorylation | SDSALHQSTMTPTQP CCCCCCCCCCCCCCC | 14.92 | 30278072 | |
| 159 | Phosphorylation | DSALHQSTMTPTQPE CCCCCCCCCCCCCCC | 20.63 | 23927012 | |
| 161 | Phosphorylation | ALHQSTMTPTQPESF CCCCCCCCCCCCCCC | 24.23 | 23927012 | |
| 163 | Phosphorylation | HQSTMTPTQPESFSS CCCCCCCCCCCCCCC | 47.81 | 23927012 | |
| 165 (in isoform 2) | Phosphorylation | - | 41.50 | 24719451 | |
| 167 | Phosphorylation | MTPTQPESFSSGSQD CCCCCCCCCCCCCCC | 36.79 | 23927012 | |
| 167 (in isoform 2) | Phosphorylation | - | 36.79 | 24719451 | |
| 169 | Phosphorylation | PTQPESFSSGSQDVH CCCCCCCCCCCCCHH | 42.97 | 23927012 | |
| 169 (in isoform 2) | Phosphorylation | - | 42.97 | 27251275 | |
| 170 | Phosphorylation | TQPESFSSGSQDVHQ CCCCCCCCCCCCHHC | 40.22 | 23927012 | |
| 172 | Phosphorylation | PESFSSGSQDVHQKR CCCCCCCCCCHHCCE | 25.75 | 17525332 | |
| 183 (in isoform 2) | Phosphorylation | - | 3.87 | 24719451 | |
| 186 (in isoform 2) | Phosphorylation | - | 31.04 | 27251275 | |
| 186 | Phosphorylation | RVLLLTVPGMEETTS EEEEEECCCCHHHCC | 31.04 | 32142685 | |
| 215 | Phosphorylation | KTGSRPKSCEVPGIN CCCCCCCCCCCCCEE | 20.42 | - | |
| 239 | Phosphorylation | TTALIPATHNTGGSL CCEEEECCCCCCCCC | 15.42 | 26074081 | |
| 242 | Phosphorylation | LIPATHNTGGSLPDL EEECCCCCCCCCCCC | 35.00 | 26074081 | |
| 245 | Phosphorylation | ATHNTGGSLPDLTNI CCCCCCCCCCCCCCC | 37.77 | 26074081 | |
| 312 | Phosphorylation | QHRPAGVSPLSLSTE CCCCCCCCCCCCCHH | 21.14 | 29255136 | |
| 315 | Phosphorylation | PAGVSPLSLSTEARR CCCCCCCCCCHHHHH | 24.53 | 27732954 | |
| 317 | Phosphorylation | GVSPLSLSTEARRQQ CCCCCCCCHHHHHHH | 22.33 | 27732954 | |
| 318 | Phosphorylation | VSPLSLSTEARRQQA CCCCCCCHHHHHHHC | 38.67 | 27732954 | |
| 330 | Phosphorylation | QQASPTLSPLSPITQ HHCCCCCCCCCHHHH | 26.69 | - | |
| 333 | Phosphorylation | SPTLSPLSPITQAVA CCCCCCCCHHHHHHH | 20.03 | 21552520 | |
| 401 | Phosphorylation | PGGPLLPSASLTRGP CCCCCCCCHHCCCCC | 30.38 | 28555341 | |
| 403 | Phosphorylation | GPLLPSASLTRGPQP CCCCCCHHCCCCCCC | 34.31 | 28555341 | |
| 419 | Phosphorylation | PLAVTVPSSLPQSPP CEEEECCCCCCCCCC | 39.92 | 28348404 | |
| 420 | Phosphorylation | LAVTVPSSLPQSPPE EEEECCCCCCCCCCC | 37.69 | 29496963 | |
| 424 | Phosphorylation | VPSSLPQSPPENPGQ CCCCCCCCCCCCCCC | 40.25 | 32142685 | |
| 436 (in isoform 2) | Phosphorylation | - | 2.31 | 27251275 | |
| 440 | Phosphorylation | SMGIDIASAPALQQY CCCCCCCCCHHHHHH | 34.81 | 32142685 | |
| 460 | Phosphorylation | SPANQSPTSPVSNQG CCCCCCCCCCCCCCC | 51.41 | 28348404 | |
| 461 | Phosphorylation | PANQSPTSPVSNQGF CCCCCCCCCCCCCCC | 27.04 | 28348404 | |
| 464 | Phosphorylation | QSPTSPVSNQGFSPG CCCCCCCCCCCCCCC | 27.16 | 28348404 | |
| 469 | Phosphorylation | PVSNQGFSPGSSPQH CCCCCCCCCCCCCCC | 34.87 | 28348404 | |
| 472 | Phosphorylation | NQGFSPGSSPQHTST CCCCCCCCCCCCHHH | 42.08 | 28348404 | |
| 473 | Phosphorylation | QGFSPGSSPQHTSTL CCCCCCCCCCCHHHH | 34.20 | 28348404 | |
| 477 | Phosphorylation | PGSSPQHTSTLGSVF CCCCCCCHHHHHHHH | 20.40 | 28348404 | |
| 478 | Phosphorylation | GSSPQHTSTLGSVFG CCCCCCHHHHHHHHH | 21.36 | 28348404 | |
| 479 | Phosphorylation | SSPQHTSTLGSVFGD CCCCCHHHHHHHHHH | 35.97 | 28348404 | |
| 480 (in isoform 2) | Phosphorylation | - | 4.89 | 27251275 | |
| 482 | Phosphorylation | QHTSTLGSVFGDAYY CCHHHHHHHHHHHHH | 19.86 | 28348404 | |
| 488 | Phosphorylation | GSVFGDAYYEQQMAA HHHHHHHHHHHHHHH | 16.57 | 28348404 | |
| 494 (in isoform 2) | Phosphorylation | - | 8.65 | 27251275 | |
| 540 | Phosphorylation | AMMGLTGSHGSLPDS HHCCCCCCCCCCCHH | 21.31 | 26074081 | |
| 543 | Phosphorylation | GLTGSHGSLPDSQQL CCCCCCCCCCHHHHH | 31.16 | 26074081 | |
| 564 | Phosphorylation | GIPNIILTVTGESPP CCCCEEEEEECCCCC | 12.96 | 26657352 | |
| 566 | Phosphorylation | PNIILTVTGESPPSL CCEEEEEECCCCCCC | 29.96 | 26657352 | |
| 569 | Phosphorylation | ILTVTGESPPSLSKE EEEEECCCCCCCCHH | 43.38 | 26074081 | |
| 571 (in isoform 3) | Phosphorylation | - | 58.12 | - | |
| 572 | Phosphorylation | VTGESPPSLSKELTS EECCCCCCCCHHHHH | 48.97 | 26074081 | |
| 574 | Phosphorylation | GESPPSLSKELTSSL CCCCCCCCHHHHHHH | 28.55 | 26074081 | |
| 578 | Phosphorylation | PSLSKELTSSLAGVG CCCCHHHHHHHCCCC | 19.84 | 27732954 | |
| 579 | Phosphorylation | SLSKELTSSLAGVGD CCCHHHHHHHCCCCC | 35.66 | 27732954 | |
| 580 | Phosphorylation | LSKELTSSLAGVGDV CCHHHHHHHCCCCCC | 19.60 | 27732954 | |
| 588 | Phosphorylation | LAGVGDVSFDSDSQF HCCCCCCCCCCCCCC | 28.24 | 27732954 | |
| 591 | Phosphorylation | VGDVSFDSDSQFPLD CCCCCCCCCCCCCHH | 36.83 | 27732954 | |
| 593 | Phosphorylation | DVSFDSDSQFPLDEL CCCCCCCCCCCHHHC | 37.36 | 27732954 | |
| 604 (in isoform 2) | Phosphorylation | - | 30.62 | 27251275 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 151 | S | Phosphorylation |
| 16817901 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CRTC1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| M3K1_HUMAN | MAP3K1 | physical | 18784253 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151 AND THR-161, ANDMASS SPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151 AND SER-172, ANDMASS SPECTROMETRY. | |
| "Silencing the constitutive active transcription factor CREB by theLKB1-SIK signaling cascade."; Katoh Y., Takemori H., Lin X.-Z., Tamura M., Muraoka M., Satoh T.,Tsuchiya Y., Min L., Doi J., Miyauchi A., Witters L.A., Nakamura H.,Okamoto M.; FEBS J. 273:2730-2748(2006). Cited for: FUNCTION, PHOSPHORYLATION AT SER-151, AND SUBCELLULAR LOCATION. | |